Access to health products: which priorities and what role for MSF?
Director of studies at Crash / Médecins sans Frontières, Michaël Neuman graduated in Contemporary History and International Relations (University Paris-I). He joined Médecins sans Frontières in 1999 and has worked both on the ground (Balkans, Sudan, Caucasus, West Africa) and in headquarters (New York, Paris as deputy director responsible for programmes). He has also carried out research on issues of immigration and geopolitics. He is co-editor of "Humanitarian negotiations Revealed, the MSF experience" (London: Hurst and Co, 2011). He is also the co-editor of "Saving lives and staying alive. Humanitarian Security in the Age of Risk Management" (London: Hurst and Co, 2016).
On 3rd and 4th February 2022, the CRASH organised a workshop aimed principally at the directors and operational managers of MSF Operational Centre Paris (OCP) to reflect on current debates, and to determine which elements of the discussion would be the most relevant to resolve in order to support the advancement of MSF OCP’s operational projects. Is access to medicines the same issue today as it was when MSF first became interested in the mid-1990s? Rather than just concentrating on the obstacles to accessing medicines, should the debate be broadened to encompass what are now called ‘health products’ or even further, towards access to care and thus largely structural problems of human resources, financing, or the absence of national health insurance policies?
We aimed to address these questions via four roundtables that each examined an important issue we want to tackle together, selected from current and future struggles felt to be priorities in our practice and our operational portfolio: vaccines for tuberculosis, malaria and beyond; the approach to tuberculosis and antibiotic resistance; the management of cancer patients; and issues in nutrition, malaria and paediatric health in general.
The Cahier can be downloaded in whole in PDF format. The two introductory chapters are available online, below.
A l'aide de rappels historiques et d'exemples concrets, Rony Brauman analyse les responsabilités respectifs des divers acteurs (laboratoires, gouvernements, institutions, ONG) dans le déficit d'accès aux soins.
The Drugs for Neglected Diseases initiative (DNDi) and other researchers, including MSF-Crash Dr. Jean Hervé Bradol, report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development (R&D) efforts.
Humanitaire ou non, la médecine est d'abord la médecine. Elle soigne des hommes et non des statistiques. A partir de récit d'expériences, d'enquêtes et d'études comparatives, ce livre propose une réflexion sur la diversité et les enjeux des pratiques médicales dans le monde.
To cite this content :
Michaël Neuman, Natalie Roberts, Access to health products: which priorities and what role for MSF?, 26 mai 2023, Collection : Cahiers du Crash, Pages : 94, URL : https://msf-crash.org/en/medicine-and-public-health/access-health-products-which-priorities-and-what-role-msf
If you want to criticize or develop this content, you can find us on twitter or directly on our site.Contribute